Gregory S. Martin - 09 Apr 2026 Form 4/A - Amendment Insider Report for Ionetix Corp / DE /

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4/A - Amendment
Accepted by SEC
13 May 2026, 14:29:54 UTC
Original report date
22 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phieu Phun, as Attorney-in-Fact for Gregory S. Martin

Key filing fact

Gregory S. Martin filed Form 4/A - Amendment for Ionetix Corp / DE / on 13 May 2026.

Key facts

  • This page summarizes Gregory S. Martin's Form 4/A - Amendment filing for Ionetix Corp / DE /.
  • 8 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 13 May 2026, 14:29.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002129828 Primary reporting owner

Martin Gregory Scott

Relationship
Director
Address
C/O IONETIX CORPORATION, 3130 SOVEREIGN DRIVE, LANSING
Signature
/s/ Phieu Phun, as Attorney-in-Fact for Gregory S. Martin
Signature date
13 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Common Stock

Award

Transaction value
Shares
+180,291
Change %
Price
Shares after
180,291
Date
09 Apr 2026
Ownership
Direct
Footnotes
F1
No ticker transaction

Common Stock

Award

Transaction value
Shares
+123,767
Change %
Price
Shares after
123,767
Date
09 Apr 2026
Ownership
By Shamrock Ionetix LLC
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+18,803
Change %
Price
Shares after
18,803
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
18,803
Exercise price
$0.3800
Footnotes
F4, F5
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+25,070
Change %
Price
Shares after
25,070
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,070
Exercise price
$0.3800
Footnotes
F4, F5
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+25,070
Change %
Price
Shares after
25,070
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,070
Exercise price
$0.9800
Footnotes
F5, F6
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+25,070
Change %
Price
Shares after
25,070
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,070
Exercise price
$0.9800
Footnotes
F5, F7
No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+25,070
Change %
Price
Shares after
25,070
Date
09 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,070
Exercise price
$0.9800
Footnotes
F5, F8
No ticker transaction Derivative

Warrant (Right to Buy)

Award

Transaction value
Shares
+193
Change %
Price
$0.000000*
Shares after
193
Date
09 Apr 2026
Ownership
By Shamrock Ionetix LLC
Underlying class
Common Stock
Underlying amount
193
Exercise price
$2.79
Footnotes
F3, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Received in connection with the Issuer's merger (the "Merger") with Ionetix Corporation ("Legacy Ionetix") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated as of April 9, 2026 (the "Merger Agreement"), by and among the Issuer (f/k/a JDEV Acquisition Corp.), JDEV Merger Subsidiary and Legacy Ionetix. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Ionetix common stock was entitled to receive 0.5014 shares of the Issuer's Common Stock. The Merger closed on April 9, 2026.

Footnote F2

Shares held of record by Shamrock Ionetix LLC. The Reporting Person's interest in Shamrock Ionetix LLC consists of a capital investment and a profits (carried) interest entitling the Reporting Person to up to 10% of the profits realized by Shamrock Ionetix LLC on its investment in Ionetix. The 123,767 shares reported in Table I represent the post-Merger equivalent of Shamrock Ionetix LLC's Legacy Ionetix holdings (229,375 shares of Series E Preferred Stock, 14,452 shares of Series F Preferred Stock, and 3,016 shares of Common Stock), converted at the 0.5014 Conversion Ratio pursuant to the Merger Agreement.

Footnote F3

Voting and investment power over the securities held by Shamrock Ionetix LLC is held solely by Stanley P. Gold. The Reporting Person disclaims beneficial ownership of the securities held by Shamrock Ionetix LLC except to the extent of his pecuniary interest therein.

Footnote F4

The stock option is fully vested and exercisable.

Footnote F5

Received in connection with the Merger in exchange for options to acquire shares of Legacy Ionetix common stock adjusted by the Conversion Ratio.

Footnote F6

The stock option vests in 48 monthly installments, subject to a one-year cliff, with vesting commencing on March 17, 2024.

Footnote F7

The stock option vests in 48 monthly installments, subject to a one-year cliff, with vesting commencing on March 17, 2023.

Footnote F8

The stock option vests in 48 monthly installments, subject to a one-year cliff, with vesting commencing on March 17, 2025.

Footnote F9

The warrant is fully vested and exercisable. The warrant was assumed by the Issuer in the Merger described in footnote (1) and is exercisable solely for shares of the Issuer's Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .